查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1293676

細胞系開發市場：按類型、來源、產品、應用分類 - 俄羅斯-烏克蘭衝突和高通脹 - 2023-2030 年全球預測

Cell Line Development Market by Type, Source, Product, Application - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球細胞系探索市場將達到56.9155億美元，複合年增長率為14.32%，2030年將達到145.4975億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球細胞系開發市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4.市場趨勢：全面了解俄羅斯-烏克蘭衝突和高通脹。

5.競爭評估和信息：對主要公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.全球細胞系開發市場規模及預測是多少？

2. 在預測期內，COVID-19 對全球細胞系開發市場的抑制因素和影響是什麼？

3.預測期內應投資全球細胞系探索市場的哪些產品/細分市場/應用/領域？

4.你們在全球細胞系開發市場的競爭策略是什麼？

5.全球細胞系開發市場的技術趨勢和監管框架是什麼？

6.全球細胞系開發市場主要廠商的市場份額是多少？

7.什麼形式和戰略舉措適合進入全球細胞系開發市場？

目錄

第一章前言

第二章研究方法

第 3 章執行摘要

第四章市場概述

第 5 章市場洞察

  • 市場動態
    • 促進因素
      • 由於應用的增加，對單克隆抗體的需求增加
      • 創新技術以及研究機構和政府機構的更多參與
      • 增加疫苗產量
    • 抑制因素
      • 產品和應用認知度低、成本高
    • 機會
      • 患傳染病的風險增加
      • 低收入國家的可能性
    • 作業
      • 開發真實且穩定的細胞系
  • 市場趨勢
  • 新冠肺炎 (COVID-19) 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通脹的累積影響
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制
    • 技術進步
      • 甲氨蝶呤放大技術
      • 谷氨□胺合成□技術
      • 基於病毒的技術

第 6 章細胞系開發市場：按類型

  • 連續細胞系
  • 雜交瘤
  • 原代細胞系
  • 重組細胞系

第 7 章細胞系開發市場：按來源

  • 兩棲動物
  • 昆蟲
  • 哺乳動物

第 8 章細胞系開發市場：按產品

  • 設備
    • 自動化系統
    • 生物反應器
    • 生物安全櫃
    • 細胞計數器和活力系統
    • 離心機
    • 過濾系統
    • 孵化器
    • 顯微鏡
    • 存儲設備
  • 培養基和試劑
    • 媒體
      • 所需的最少介質
      • 血清培養基減少
      • 無血清培養基
    • 試劑
      • 緩沖劑和化學品
      • 細胞解離試劑
      • 冷凍保存試劑
      • 補充劑和生長因子
    • 血清
      • 成年牛血清
      • 胎牛血清

第 9 章細胞系開發市場：按應用劃分

  • 生物生產
    • 診斷
    • 重組蛋白療法
    • 疫苗生產
  • 藥物發現
    • 疾病建模
    • 藥物篩選和開發
    • 目標驗證
  • 調查
  • 組織工程和再生醫學
  • 毒性測試

第10章北美和南美細胞系開發市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區細胞系開發市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第十二章歐洲、中東和非洲的細胞系開發市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第13章競爭態勢

  • FPNV定位矩陣
  • 市場份額分析：按主要公司劃分
  • 競爭情景分析：主要公司

第14章上市公司名單

第15章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-43078BB92CD4

The Global Cell Line Development Market is forecasted to grow significantly, with a projected USD 5,691.55 million in 2023 at a CAGR of 14.32% and expected to reach a staggering USD 14,549.75 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell Line Development Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell Line Development Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines. The Continuous Cell Lines commanded largest market share of 31.21% in 2022, followed by Primary Cell Lines.

Based on Source, market is studied across Amphibian, Insect, and Mammalian. The Mammalian commanded largest market share of 41.31% in 2022, followed by Insect.

Based on Product, market is studied across Equipment and Media and Reagents. The Equipment is further studied across Automated Systems, Bioreactors, Biosafety Cabinets, Cell Counters and Viability Systems, Centrifuges, Filtration Systems, Incubators, Microscopes, and Storage Equipment. The Media and Reagents is further studied across Media, Reagents, and Serum. The Media is further studied across Minimum Essential Media, Reduced Serum Media, and Serum-free Media. The Reagents is further studied across Buffers and Chemicals, Cell Dissociation Reagents, Cryopreservative Reagents, and Supplements and Growth Factors. The Serum is further studied across Adult Bovine Serum and Fetal Bovine Serum. The Media and Reagents commanded largest market share of 69.37% in 2022, followed by Equipment.

Based on Application, market is studied across Bioproduction, Drug Discovery, Research, Tissue Engineering & Regenerative Medicine, and Toxicity Testing. The Bioproduction is further studied across Diagnostics, Recombinant Protein Therapeutics, and Vaccine Production. The Drug Discovery is further studied across Disease Modeling, Drug Screening and Development, and Target Validation. The Bioproduction commanded largest market share of 31.95% in 2022, followed by Drug Discovery.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 35.57% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell Line Development Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell Line Development Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Line Development Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Line Development Market?

4. What is the competitive strategic window for opportunities in the Global Cell Line Development Market?

5. What are the technology trends and regulatory frameworks in the Global Cell Line Development Market?

6. What is the market share of the leading vendors in the Global Cell Line Development Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell Line Development Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Line Development Market, by Type, 2022 vs 2030
  • 4.3. Cell Line Development Market, by Source, 2022 vs 2030
  • 4.4. Cell Line Development Market, by Product, 2022 vs 2030
  • 4.5. Cell Line Development Market, by Application, 2022 vs 2030
  • 4.6. Cell Line Development Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase Demand for Monoclonal Antibodies Owing to Increase Application
      • 5.1.1.2. Innovative Technologies Coupled with Increased Participation of Research Institutes and Government Agency
      • 5.1.1.3. Growing Rise in Vaccine Production
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Awareness and High Cost Associated with The Product and Applications
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Risk of Communicable Epidemics Diseases
      • 5.1.3.2. Potential in Low-income Countries
    • 5.1.4. Challenges
      • 5.1.4.1. Developing Authentic and Stable Cell Lines
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Technology Advancement
      • 5.9.1.1. Methotrexate Amplification Technology
      • 5.9.1.2. Glutamine Synthatase Technology
      • 5.9.1.3. Viral-Based Technology

6. Cell Line Development Market, by Type

  • 6.1. Introduction
  • 6.2. Continuous Cell Lines
  • 6.3. Hybridomas
  • 6.4. Primary Cell Lines
  • 6.5. Recombinant Cell Lines

7. Cell Line Development Market, by Source

  • 7.1. Introduction
  • 7.2. Amphibian
  • 7.3. Insect
  • 7.4. Mammalian

8. Cell Line Development Market, by Product

  • 8.1. Introduction
  • 8.2. Equipment
    • 8.2.1. Automated Systems
    • 8.2.2. Bioreactors
    • 8.2.3. Biosafety Cabinets
    • 8.2.4. Cell Counters and Viability Systems
    • 8.2.5. Centrifuges
    • 8.2.6. Filtration Systems
    • 8.2.7. Incubators
    • 8.2.8. Microscopes
    • 8.2.9. Storage Equipment
  • 8.3. Media and Reagents
    • 8.3.1. Media
      • 8.3.1.1. Minimum Essential Media
      • 8.3.1.2. Reduced Serum Media
      • 8.3.1.3. Serum-free Media
    • 8.3.2. Reagents
      • 8.3.2.1. Buffers and Chemicals
      • 8.3.2.2. Cell Dissociation Reagents
      • 8.3.2.3. Cryopreservative Reagents
      • 8.3.2.4. Supplements and Growth Factors
    • 8.3.3. Serum
      • 8.3.3.1. Adult Bovine Serum
      • 8.3.3.2. Fetal Bovine Serum

9. Cell Line Development Market, by Application

  • 9.1. Introduction
  • 9.2. Bioproduction
    • 9.2.1. Diagnostics
    • 9.2.2. Recombinant Protein Therapeutics
    • 9.2.3. Vaccine Production
  • 9.3. Drug Discovery
    • 9.3.1. Disease Modeling
    • 9.3.2. Drug Screening and Development
    • 9.3.3. Target Validation
  • 9.4. Research
  • 9.5. Tissue Engineering & Regenerative Medicine
  • 9.6. Toxicity Testing

10. Americas Cell Line Development Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Line Development Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Line Development Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

1. AGC Biologics

2. Aragen Bioscience, Inc.

3. Boehringer Ingelheim International GmbH

4. Catalent, Inc.

5. Corning Incorporated

6. EuBiologics Co.,Ltd.

7. GE Healthcare

8. Genscript Biotech

9. Lonza Group AG

10. Merck KGaA

11. Rentschler Biopharma SE

12. Samsung Biologics Co., Ltd.

13. Sartorius AG

14. Selexis SA

15. Thermo Fisher Scientific Inc.

16. Vista Biologicals Corporation

17. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. CELL LINE DEVELOPMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CELL LINE DEVELOPMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL LINE DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 6. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 7. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CELL LINE DEVELOPMENT MARKET DYNAMICS
  • FIGURE 10. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CELL LINE DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CELL LINE DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL LINE DEVELOPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL LINE DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. CELL LINE DEVELOPMENT MARKET SIZE, BY CONTINUOUS CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CELL LINE DEVELOPMENT MARKET SIZE, BY HYBRIDOMAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL LINE DEVELOPMENT MARKET SIZE, BY PRIMARY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 10. CELL LINE DEVELOPMENT MARKET SIZE, BY AMPHIBIAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL LINE DEVELOPMENT MARKET SIZE, BY INSECT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL LINE DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 15. CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL LINE DEVELOPMENT MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL LINE DEVELOPMENT MARKET SIZE, BY CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CELL LINE DEVELOPMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CELL LINE DEVELOPMENT MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CELL LINE DEVELOPMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. CELL LINE DEVELOPMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CELL LINE DEVELOPMENT MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 26. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 28. CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. CELL LINE DEVELOPMENT MARKET SIZE, BY MINIMUM ESSENTIAL MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. CELL LINE DEVELOPMENT MARKET SIZE, BY REDUCED SERUM MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 33. CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. CELL LINE DEVELOPMENT MARKET SIZE, BY BUFFERS AND CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. CELL LINE DEVELOPMENT MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. CELL LINE DEVELOPMENT MARKET SIZE, BY CRYOPRESERVATIVE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. CELL LINE DEVELOPMENT MARKET SIZE, BY SUPPLEMENTS AND GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 39. CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. CELL LINE DEVELOPMENT MARKET SIZE, BY ADULT BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. CELL LINE DEVELOPMENT MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 44. CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. CELL LINE DEVELOPMENT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEIN THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. CELL LINE DEVELOPMENT MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 49. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. CELL LINE DEVELOPMENT MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG SCREENING AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. CELL LINE DEVELOPMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. CELL LINE DEVELOPMENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. CELL LINE DEVELOPMENT MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. CELL LINE DEVELOPMENT MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 241. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 242. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 243. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 252. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 253. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 254. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 263. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 264. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 265. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 267. VIETNAM CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 286. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 287. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 288. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 289. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 290. DENMARK CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 297. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 298. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 299. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 301. EGYPT CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 308. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 309. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 310. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 311. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 312. FINLAND CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 315. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 316. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 319. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 320. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 321. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 323. FRANCE CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 324. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 326. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 330. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 331. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 332. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 334. GERMANY CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 335. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 337. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 338. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 339. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 340. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2030 (USD MILLION)
  • TABLE 341. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 342. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2030 (USD MILLION)
  • TABLE 343. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 345. ISRAEL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 346. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 347. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 348. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 349. ITALY CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 350. ITALY CELL LINE DEVELOPMENT MARKE